Literature DB >> 18937293

Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples.

Michael E Talkowski1, Lora McClain, Trina Allen, L Dianne Bradford, Monica Calkins, Neil Edwards, Lyudmila Georgieva, Rodney Go, Ruben Gur, Raquel Gur, George Kirov, Kodavali Chowdari, Joseph Kwentus, Paul Lyons, Hader Mansour, Joseph McEvoy, Michael C O'Donovan, Judith O'Jile, Michael J Owen, Alberto Santos, Robert Savage, Draga Toncheva, Gerard Vockley, Joel Wood, Bernie Devlin, Vishwajit L Nimgaonkar.   

Abstract

Recessive mutations in the phenylalanine hydroxylase (PAH) gene predispose to phenylketonuria (PKU) in conjunction with dietary exposure to phenylalanine. Previous studies have suggested PAH variations could confer risk for schizophrenia, but comprehensive follow-up has not been reported. We analyzed 15 common PAH "tag" SNPs and three exonic variations that are rare in Caucasians but common in African-Americans among four independent samples (total n = 5,414). The samples included two US Caucasian cohorts (260 trios, 230 independent cases, 474 controls), Bulgarian families (659 trios), and an African-American sample (464 families, 401 controls). Analyses of both US Caucasian samples revealed associations with five SNPs; most notably the common allele (G) of rs1522305 from case-control analyses (z = 2.99, P = 0.006). This SNP was independently replicated in the Bulgarian cohort (z = 2.39, P = 0.015). A non-significant trend was also observed among African-American families (z = 1.39, P = 0.165), and combined analyses of all four samples were significant (rs1522305: chi(2) = 23.28, 8 d.f., P = 0.003). Results for rs1522305 met our a priori criteria for statistical significance, namely an association that was robust to multiple testing correction in one sample, a replicated risk allele in multiple samples, and combined analyses that were nominally significant. Case-control results in African-Americans detected an association with L321L (P = 0.047, OR = 1.46). Our analyses suggest several associations at PAH, with consistent evidence for rs1522305. Further analyses, including additional variations and environmental influences such as phenylalanine exposure are warranted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18937293      PMCID: PMC2738981          DOI: 10.1002/ajmg.b.30862

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  39 in total

1.  Serum phenylalanine in schizophrenia: biochemical genetic aspects.

Authors:  A M POISNER
Journal:  J Nerv Ment Dis       Date:  1960-07       Impact factor: 2.254

2.  Absence of phenylketonuria in adult psychotics; a survey of 4246 inmates of a state mental hospital.

Authors:  R M CARES
Journal:  Am J Psychiatry       Date:  1956-05       Impact factor: 18.112

3.  Characterization of multilocus linkage disequilibrium.

Authors:  Alessandro Rinaldo; Silviu-Alin Bacanu; B Devlin; Vibhor Sonpar; Larry Wasserman; Kathryn Roeder
Journal:  Genet Epidemiol       Date:  2005-04       Impact factor: 2.135

4.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis.

Authors:  J R O'Connell; D E Weeks
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

Review 5.  Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.

Authors:  Hader A Mansour; Michael E Talkowski; Joel Wood; Lora Pless; Mikhil Bamne; Kodavali V Chowdari; Michael Allen; Charles L Bowden; Joseph Calabrese; Rif S El-Mallakh; Andrea Fagiolini; Stephen V Faraone; Mark D Fossey; Edward S Friedman; Laszlo Gyulai; Peter Hauser; Terence A Ketter; Jennifer M Loftis; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra Patel; Gary S Sachs; Pamela Sklar; Jordan W Smoller; Michael E Thase; Ellen Frank; David J Kupfer; Vishwajit L Nimgaonkar
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

6.  Neuropsychology of early-treated phenylketonuria: specific executive function deficits.

Authors:  M C Welsh; B F Pennington; S Ozonoff; B Rouse; E R McCabe
Journal:  Child Dev       Date:  1990-12

7.  Olfactory deficits, cognition and negative symptoms in early onset psychosis.

Authors:  Cheryl Corcoran; Agnes Whitaker; Eliza Coleman; Jane Fried; Judith Feldman; Nora Goudsmit; Dolores Malaspina
Journal:  Schizophr Res       Date:  2005-08-26       Impact factor: 4.939

8.  Delusional disorder in a boy with phenylketonuria and amine metabolites in the cerebrospinal fluid after treatment with neuroleptics.

Authors:  R S Shiwach; S Sheikha
Journal:  J Adolesc Health       Date:  1998-03       Impact factor: 5.012

9.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.

Authors:  J I Nurnberger; M C Blehar; C A Kaufmann; C York-Cooler; S G Simpson; J Harkavy-Friedman; J B Severe; D Malaspina; T Reich
Journal:  Arch Gen Psychiatry       Date:  1994-11

Review 10.  Phenylethylamine and schizophrenia.

Authors:  R L O'Reilly; B A Davis
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1994-01       Impact factor: 5.067

View more
  4 in total

1.  Revisiting schizophrenia linkage data in the NIMH Repository: reanalysis of regularized data across multiple studies.

Authors:  Veronica J Vieland; Kimberly A Walters; Thomas Lehner; Marco Azaro; Kathleen Tobin; Yungui Huang; Linda M Brzustowicz
Journal:  Am J Psychiatry       Date:  2014-03       Impact factor: 18.112

2.  13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients.

Authors:  T Teraishi; Y Ozeki; H Hori; D Sasayama; S Chiba; N Yamamoto; H Tanaka; Y Iijima; J Matsuo; Y Kawamoto; Y Kinoshita; K Hattori; M Ota; M Kajiwara; S Terada; T Higuchi; H Kunugi
Journal:  Transl Psychiatry       Date:  2012-05-22       Impact factor: 6.222

3.  Possible association between common variants of the phenylalanine hydroxylase (PAH) gene and memory performance in healthy adults.

Authors:  Toshiya Teraishi; Daimei Sasayama; Hiroaki Hori; Noriko Yamamoto; Takashi Fujii; Junko Matsuo; Anna Nagashima; Yukiko Kinoshita; Kotaro Hattori; Miho Ota; Sayaka Fujii; Hiroshi Kunugi
Journal:  Behav Brain Funct       Date:  2013-07-30       Impact factor: 3.759

4.  Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia.

Authors:  Ashwin Jacob Mathai; Jyoti Kanwar; Olaoluwa Okusaga; Dietmar Fuchs; Christopher A Lowry; Xiaoqing Peng; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Claudia Gragnoli; Gloria M Reeves; Maureen W Groer; Richard N Rosenthal; Dan Rujescu; Teodor T Postolache
Journal:  Front Public Health       Date:  2016-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.